Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral minoxidil may help hair regrowth in female cancer survivors.

Indometacin was chosen for a gel to help treat mastopathy and prevent breast cancer.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

More research needed to confirm finasteride as standard treatment for FFA.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Aromatase inhibitors cause male pattern hair loss in women.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Estrogen therapy can reduce skin aging but has cancer risks.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.